Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrea Paul Insider Profile
4 Followers
Andrea Paul, GC & Secretary at Logicbio Therapeutics, holds ― shares in Logicbio Therapeutics (Ticker: LOGC), holds 149.97K shares in Zentalis Pharmaceuticals (Ticker: ZNTL). Most recently, Andrea Paul ― shares of Logicbio Therapeutics on ― for an estimated value of ―.
Andrea Paul Logicbio Therapeutics (LOGC)GC & Secretary
Logicbio Therapeutics (LOGC)
GC & Secretary
Not Ranked
Andrea Paul has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CLO
Roles that Andrea Paul holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrea Paul
Andrea Paul's Trading History
Logicbio Therapeutics
―
―
―
―
Zentalis Pharmaceuticals
Feb 05, 2024
CLO
Uninformative Buy
―
$1.85M
List of latest transactions for each holding click on a transaction to see Andrea Paul's performance on stock
You May Also Like
Andrea Paul insider profile FAQ
What is the percentage of profitable transactions made by Andrea Paul?
The percentage of profitable transactions made by Andrea Paul is ―.
What is the average return per transaction made by Andrea Paul?
The average return per transaction made by Andrea Paul is ―.
What stocks does Andrea Paul hold?
Andrea Paul holds: LOGC, ZNTL stocks.
What was Andrea Paul’s latest transaction?
Andrea Paul latest transaction was an Uninformative Buy of ―.
What was Andrea Paul's most profitable transaction?
Andrea Paul’s most profitable transaction was an Informative Sell of ZNTL stock on February 5, 2024. The return on the trade was -3.00%.
What is Andrea Paul's role in Logicbio Therapeutics?
Andrea Paul's role in Logicbio Therapeutics is GC & Secretary.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.